Web Analytics
top of page

  • The Benefits and Pitfalls of Repurposing Drugs*

  • Can Health Technology Assessment be Used to Demonstrate Significant Benefit for an Orphan Medicinal Product in the EU

  • Is Orphan Drug Status the Answer to Everyone’s Prayers?*

  • Cost of Degenerative Cervical Myelopathy to UK society

*In association with Phetairos

    © 2025 The Goffin Consultancy. All Rights Reserved

    bottom of page